Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice

Brain Research Bulletin

Volumn 84, Issue 2, 2011, Pages 163-168

  Chen, Tao ^a   Liu, WenBo ^a   Chao, XiaoDong ^a   Zhang, Lei ^a   Qu, Yan ^a   Huo, JunLi ^a   Fei, Zhou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti inflammation; Cytokines; Neuroprotection; Salvianolic acid B; Traumatic brain injury

Indexed keywords

INTERLEUKIN 1BETA; SALVIANOLIC ACID B; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN TISSUE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MICROGLIA; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL MEMORY; TISSUE HOMOGENATE; TRAUMATIC BRAIN INJURY;

ANIMALS; BENZOFURANS; BRAIN EDEMA; BRAIN INJURIES; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; LEARNING; MALE; MEMORY; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; SPACE PERCEPTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79451471769     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.11.015     Document Type: Article

References (42)

1. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 1996, 16:2945-2955.
2. Bermpohl D., You Z., Korsmeyer S.J., Moskowitz M.A., Whalen M.J. Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome. J. Cereb. Blood Flow Metab. 2006, 26:625-633.
3. Bermpohl D., You Z., Lo E.H., Kim H.H., Whalen M.J. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2007, 27:1806-1818.
4. Bramlett H.M., Dietrich W.D. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog. Brain Res. 2007, 161:125-141.
5. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 1995, 9:355-365.
6. Chao X., Zhou J., Chen T., Liu W., Dong W., Qu Y., Jiang X., Ji X., Zhen H., Fei Z. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res. 2010.
7. Chen Y.H., Du G.H., Zhang J.T. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol. Sin. 2000, 21:463-466.
8. Chen Y.H., Lin S.J., Ku H.H., Shiao M.S., Lin F.Y., Chen J.W., Chen Y.L. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J. Cell. Biochem. 2001, 82:512-521.
9. Chen Y.L., Hu C.S., Lin F.Y., Chen Y.H., Sheu L.M., Ku H.H., Shiao M.S., Chen J.W., Lin S.J. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J. Cell. Biochem. 2006, 98:618-631.
10. Chua K.S., Ng Y.S., Yap S.G., Bok C.W. A brief review of traumatic brain injury rehabilitation. Ann. Acad. Med. Singapore 2007, 36:31-42.
11. Correale J., Villa A. The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 2004, 251:1304-1316.
12. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., Joller H., Trentz O., Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J. Neuroimmunol. 1999, 101:211-221.
13. Davis A.E. Cognitive impairments following traumatic brain injury. Etiologies and interventions. Crit. Care Nurs. Clin. North Am. 2000, 12:447-456.
14. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
15. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
16. Imanshahidi M., Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytother. Res. 2006, 20:427-437.
17. Israelsson C., Bengtsson H., Kylberg A., Kullander K., Lewen A., Hillered L., Ebendal T. Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J. Neurotrauma 2008, 25:959-974.
18. Ji X.Y., Tan B.K., Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 2000, 21:1089-1094.
19. Jones N.C., Prior M.J., Burden-Teh E., Marsden C.A., Morris P.G., Murphy S. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur. J. Neurosci. 2005, 22:72-78.
20. Kaushal V., Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 2008, 28:2221-2230.
21. Lin S.J., Lee I.T., Chen Y.H., Lin F.Y., Sheu L.M., Ku H.H., Shiao M.S., Chen J.W., Chen Y.L. Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells. J. Cell. Biochem. 2007, 100:372-384.
22. Lynch J.R., Wang H., Mace B., Leinenweber S., Warner D.S., Bennett E.R., Vitek M.P., McKenna S., Laskowitz D.T. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp. Neurol. 2005, 192:109-116.
23. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008, 7:728-741.
24. Mammis A., McIntosh T.K., Maniker A.H. Erythroprotein as a neuroprotective agent in traumatic brain injury review. Surg. Neurol. 2009, 71:527-531. (discussion 531).
25. McAllister T.W. Psychopharmacological issues in the treatment of TBI and PTSD. Clin. Neuropsychol. 2009, 23:1338-1367.
26. McKeating E.G., Andrews P.J., Mascia L. The relationship of soluble adhesion molecule concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Anesth. Analg. 1998, 86:759-765.
27. Morganti-Kossmann M.C., Rancan M., Otto V.I., Stahel P.F., Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001, 16:165-177.
28. Ooboshi H., Ibayashi S., Shichita T., Kumai Y., Takada J., Ago T., Arakawa S., Sugimori H., Kamouchi M., Kitazono T., Iida M. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 2005, 111:913-919.
29. Pang L., Ye W., Che X.M., Roessler B.J., Betz A.L., Yang G.Y. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 2001, 32:544-552.
30. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17:942-964. (table of contents).
31. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J. Neuroimmunol. 1997, 72:169-177.
32. Tang M., Feng W., Zhang Y., Zhong J., Zhang J. Salvianolic acid B improves motor function after cerebral ischemia in rats. Behav. Pharmacol. 2006, 17:493-498.
33. Tian J., Fu F., Li G., Wang Y., Gao Y., Liu Z., Zhang S., SMND-309 a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: characterization and role. Brain Res. 2009, 1263:114-121.
34. Tolias C.M., Bullock M.R. Critical appraisal of neuroprotection trials in head injury: what have we learned?. NeuroRx 2004, 1:71-79.
35. Townsend K.P., Pratico D. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005, 19:1592-1601.
36. Wahl S.M. Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 1994, 180:1587-1590.
37. Wang S.X., Hu L.M., Gao X.M., Guo H., Fan G.W. Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect. Neurochem. Res. 2010, 35:1029-1037.
38. Winter C.D., Iannotti F., Pringle A.K., Trikkas C., Clough G.F., Church M.K. A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. J. Neurosci. Meth. 2002, 119:45-50.
39. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 1991, 33:227-236.
40. Yu S.S., Zhao J., Zheng W.P., Zhao Y. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats. Brain Res. 2010, 1308:167-175.
41. Zhou L., Zuo Z., Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45:1345-1359.
42. Zhou Z., Liu Y., Miao A.D., Wang S.Q. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells. J. Cell. Biochem. 2005, 96:109-116.